Unisciti a myPOCacademy, è gratuito
e i corsi sono accreditati CPD
JOIN
Presentazioni
-
Prof. Nicholas Francis
(UK)
ChairSafe reduction of antibiotics for acute exacerbations of chronic obstructive pulmonary disease using CRP point-of-care testing: The findings of the PACE Study.
-
Prof. Rogier Hopstaken
(The Netherlands)
SpeakerReduction of antibiotic prescribing at primary care: Evidence of the established role of CRP point-of-care testing.
-
-
Le opinioni e le opinioni presentate sono solo degli autori. Il contenuto di questo webcast è destinato esclusivamente a scopi informativi/didattici.
Unisciti a <strong>myPOCacademy</strong>, è <strong>gratuito</strong><br>e i corsi sono <strong>accreditati CPD</strong>
JOINBackground
Join our panel of experts from across Europe to learn about the value of C-reactive protein (CRP) point-of-care testing (POCT) to help fight antimicrobial resistance and as an aid to help avoid the misuse of antibiotics. 90% of respiratory tract infections (RTIs) are viral and therefore antibiotics have no clinical benefit. And yet RTIs are one of the most common reasons for unnecessary antibiotic prescribing [1]. The webinar will analyse studies and present front-line experience on the value of CRP POCT told through the eyes of internationally acclaimed healthcare professionals and academics from the UK, the Netherlands and Italy.
Le opinioni e le opinioni presentate sono solo degli autori. Il contenuto di questo webcast è destinato esclusivamente a scopi informativi/didattici.
- ↑ CDC. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Update 27. Oct 2020. Downloaded June 2021. https://stacks.cdc.gov/view/cdc/89980
© 2022 Abate. Tutti i diritti riservati. Tutti i marchi citati sono marchi del gruppo di società Abbott o dei rispettivi proprietari. COL-00000
Unisciti a <strong>myPOCacademy</strong>, è <strong>gratuito</strong><br>e i corsi sono <strong>accreditati CPD</strong>
JOIN